Table 8.

Study A: estimated mean values from mixed models of relative changes [%] of laboratory parameters from pre to postdialysis and P values of specified comparisons by study phase, including period and treatment and interaction term between period and treatment

OverallaP Value
Membrane Type (in HD)Treatment Modality
Dialyzer/ ModalityFX 100 HDFX CorDiax 100 HDFX CorDiax 100 HDFFX 100 versus FX CorDiax 100FX CorDiax 100 (HD) FX CorDiax 100 (HDF)
TAT383.37672.761068.330.0020.110.03
IgE6.865.686.470.750.460.62
hsCRP4.424.612.920.760.940.50
IL-8−20.82−24.56−34.970.0040.360.01
  • HD, hemodialysis; HDF, hemodiafiltration; TAT, thrombin-antithrombin; hsCRP, high-sensitivity C-reactive protein.

  • a The overall P value displays the P value for analyzing differences between all three or four groups, respectively.